Fast Moving Stocks: Talisman Energy Inc. (NYSE:TLM), Receptos (NASDAQ:RCPT), Prana Biotechnology Limited (NASDAQ:PRAN), Great Lakes Dredge & Dock (NASDAQ:GLDD), Gannett Co. (NYSE:GCI)

Oil producers have been focusing on preserving their financial strength in order to prepare for what could be a tough crude pricing environment next year. Even so, Talisman Energy Inc. (NYSE:TLM) could struggle beyond pricing as it does not generate enough cash to meet its capital requirements. Talisman Energy Inc. (NYSE:TLM) belongs to Basic Materials sector. Its net profit margin is -7.20% and weekly performance … Continue reading Fast Moving Stocks: Talisman Energy Inc. (NYSE:TLM), Receptos (NASDAQ:RCPT), Prana Biotechnology Limited (NASDAQ:PRAN), Great Lakes Dredge & Dock (NASDAQ:GLDD), Gannett Co. (NYSE:GCI)

Adam Keintzel12/0112/01

Morning Watch List: BlackBerry Ltd (NASDAQ:BBRY), Receptos (NASDAQ:RCPT), Ceres (NASDAQ:CERE), Zafgen, Inc. (NASDAQ:ZFGN), Quintiles Transnational Holdings Inc. (NYSE:Q)

BlackBerry Ltd. (BBRY) has once again secured a victory against Typo Products LLC, a company co-founded by American television host and producer Ryan Seacrest. The smartphone maker filed a lawsuit with the US District Court of the Northern District of California against Typo Products in January, on grounds that Typo Product’s QWERTY keyboard, designed to be attached to iPhones, infringed on the Blackberry’s patents. BlackBerry Ltd … Continue reading Morning Watch List: BlackBerry Ltd (NASDAQ:BBRY), Receptos (NASDAQ:RCPT), Ceres (NASDAQ:CERE), Zafgen, Inc. (NASDAQ:ZFGN), Quintiles Transnational Holdings Inc. (NYSE:Q)

Colin Pettis08/2608/26

Biotech Unusual Volume: Aldeyra Therapeutics (NASDAQ:ALDX), Alcobra (NASDAQ:ADHD), Receptos (NASDAQ:RCPT), Celsus Therapeutics (NASDAQ:CLTX)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) rallied to a new all-time high Thursday after Aegis Capital began coverage of the biotech company working to develop treatments for rare skin and eye diseases with a Buy rating. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was 12.26% in last session and finished the day at $7.51. Traded volume was 134,905.00million shares in the last session and the average volume of … Continue reading Biotech Unusual Volume: Aldeyra Therapeutics (NASDAQ:ALDX), Alcobra (NASDAQ:ADHD), Receptos (NASDAQ:RCPT), Celsus Therapeutics (NASDAQ:CLTX)

John Meady06/2006/20

Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is up over 16% today on news of the company’s initiation of phase-II trials for its lead drug candidate KRN23, which is a monoclonal antibody for X-linked Hypophosphatemia (XLH). Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) stock performance was 14.30% in last session and finished the day at $48.67. Traded volume was 435,645.00million shares in the last session and the average volume of the … Continue reading Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Mark DeFrance06/1906/19

Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

On May 9, 2014, Amicus Therapeutics, Inc. (NASDAQ:FOLD) updated its Investor Presentation for the Migalastat Monotherapy Program (the “Presentation”). The Company’s Chief Financial Officer, William D. Baird III and the Company’s Chief Operating Officer, Bradley L. Campbell, will present some or all of this Presentation to various investors in the coming months. A copy of the presentation materials is attached hereto as Exhibit 99.1. Amicus … Continue reading Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

Jayne Crisman05/2305/23

Biotech Stocks Touching New Highs: BioSpecifics Technologies (NASDAQ:BSTC), NanoString Technologies (NASDAQ:NSTG), Celladon (NASDAQ:CLDN), Receptos (NASDAQ:RCPT)

BioSpecifics Technologies Corp. (NASDAQ:BSTC) released its earnings data on Thursday. The company reported $0.25 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.17 by $0.08, Stock Ratings Network.com reports. BioSpecifics Technologies Corp. (NASDAQ:BSTC) stock performance was 1.56% in last session and finished the day at $26.72. Traded volume was 32,149.00 shares in the last session and the average volume of the stock … Continue reading Biotech Stocks Touching New Highs: BioSpecifics Technologies (NASDAQ:BSTC), NanoString Technologies (NASDAQ:NSTG), Celladon (NASDAQ:CLDN), Receptos (NASDAQ:RCPT)

Adam Keintzel03/1403/14